Literature DB >> 24687300

Heart failure and dipeptidyl peptidase-4 inhibitors.

Henry Krum1, Marina Skiba, Shiying Wu, Ingrid Hopper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24687300     DOI： 10.1002/ejhf.90

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  11 in total

Review 1.  Sitagliptin: A Review in Type 2 Diabetes.

Authors:  Lesley J Scott
Journal:  Drugs       Date:  2017-02       Impact factor: 9.546

Review 2.  Insights from cardiovascular outcome trials with novel antidiabetes agents: what have we learned? An industry perspective.

Authors:  Boaz Hirshberg; Arie Katz
Journal:  Curr Diab Rep       Date:  2015-11       Impact factor: 4.810

3.  Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database.

Authors:  Sunghwan Suh; Gi Hyeon Seo; Chang Hee Jung; Mee-Kyoung Kim; Sang-Man Jin; You-Cheol Hwang; Byung-Wan Lee; Jae Hyeon Kim
Journal:  Diabetes Metab J       Date:  2015-04-22       Impact factor: 5.376

Review 4.  Saxagliptin: A Review in Type 2 Diabetes.

Authors:  Sohita Dhillon
Journal:  Drugs       Date:  2015-10       Impact factor: 9.546

5.  Dipeptidyl-peptidase-4 Inhibitors and Heart Failure: Class Effect, Substance-Specific Effect, or Chance Effect?

Authors:  Eberhard Standl; Michael Erbach; Oliver Schnell
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-12

6.  Can cardiac autonomic neuropathy be a predictor of cardiovascular outcomes in diabetes?

Authors:  Sanjay Kalra; Yashdeep Gupta; Manash Baruah
Journal:  Indian J Endocrinol Metab       Date:  2015 Mar-Apr

7.  Associations of dipeptidyl peptidase-4 inhibitors with mortality in hospitalized heart failure patients with diabetes mellitus.

Authors:  Akihiko Sato; Akiomi Yoshihisa; Yuki Kanno; Mai Takiguchi; Shunsuke Miura; Takeshi Shimizu; Yuichi Nakamura; Hiroyuki Yamauchi; Takashi Owada; Takamasa Sato; Satoshi Suzuki; Masayoshi Oikawa; Takayoshi Yamaki; Koichi Sugimoto; Hiroyuki Kunii; Kazuhiko Nakazato; Hitoshi Suzuki; Shu-Ichi Saitoh; Yasuchika Takeishi
Journal:  ESC Heart Fail       Date:  2015-11-30

8.  Comparative safety for cardiovascular outcomes of DPP-4 inhibitors versus glimepiride in patients with type 2 diabetes: A retrospective cohort study.

Authors:  Hyouk-Jun Chin; Jin Hyun Nam; Eui-Kyung Lee; Ju-Young Shin
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

Review 9.  Bedside-to-Bench Translational Research for Chronic Heart Failure: Creating an Agenda for Clients Who Do Not Meet Trial Enrollment Criteria.

Authors:  P Iyngkaran; M Thomas
Journal:  Clin Med Insights Cardiol       Date:  2015-08-05

10.  Sitagliptin and risk of heart failure hospitalization in patients with type 2 diabetes on dialysis: A population-based cohort study.

Authors:  Yi-Chih Hung; Che-Chen Lin; Wei-Lun Huang; Man-Ping Chang; Ching-Chu Chen
Journal:  Sci Rep       Date:  2016-07-27       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.